Measuring the quality of information in medical package leaflets: harmful or helpful?

Karel van der Waarde

This article is based on a presentation given at the IIID Vision Plus 12 conference ‘Achieving measurable results’ in Schwarzenberg, Austria in 2006. The following text provides an outline of a single perspective on the circumstances in 2008. There are many stakeholders involved in the development of information about medicines, and all have different concerns which influence contents and design. A single article cannot do justice to the wide variation of perspectives.

Published online: 12 December 2008
https://doi.org/10.1075/idj.16.3.05waa

Cited by

Cited by other publications

Fage-Butler, Antoinette

2015. Package leaflets for medication in the EU: The possibility of integrating patients’ perspectives in a regulated genre?. Medical Writing 24:4 ► pp. 210 ff.

Frascara, Jorge

2019. Information design from my window. Information Design Journal 25:3 ► pp. 334 ff.

Jay, Eleanor, Parisa Aslani & DK Raynor

2011. User testing of consumer medicine information in Australia. Health Education Journal 70:4 ► pp. 420 ff.

van der Waarde, Karel

2019. Information about medicines in Europe. Information Design Journal 25:3 ► pp. 307 ff.

This list is based on CrossRef data as of 30 december 2020. Please note that it may not be complete. Sources presented here have been supplied by the respective publishers. Any errors therein should be reported to them.